Buy Glenmark Pharma on dips, may hit Rs 1040: Kunal Bothra

Kunal Bothra of LKP Securities told CNBC-TV18, "Glenmark Pharma looks very attractive even though it is trading at a 4-5 percent kind of a jump right now. I still believe that the way the patterns are building up in terms of the volumes, the way it took support couple of weeks back and the move subsequent, I think there is still more steam left. So rather than being looking at bottom fishing in many names like Cipla, it is better to go with a breakout name like Glenmark Pharma."

"I believe a short-term target of at least Rs 1,020-1,040 is still possible on Glenmark Pharma. Given if you are a short-term trader you look to buy on dips but Rs 1,040 could be on cards for Glenmark Pharma," he added.